17-4 (54) 2023 — Nabieva D.A., Musashaykhov U.Х. — INVESTIGATION OF THE GENETIC ASSOCIATION OF TRY64ARG POLYMORPHISM IN THE ADRB3 GENE WITH THE RISK OF METABOLIC SYNDROME AND MYOCARDIAL INFARCTION

INVESTIGATION OF THE GENETIC ASSOCIATION OF TRY64ARG POLYMORPHISM IN THE ADRB3 GENE WITH THE RISK OF METABOLIC SYNDROME AND MYOCARDIAL INFARCTION

Nabieva D.A., Tashkent Medical Academy.

Musashaykhov U.Х., Andijan State Medical Institute.

Boboev K.T., Republican Specialized Scientific and Practical Medical Center of Hematology.

Musashaykhov Х.T. Andijan State Medical Institute.

Resume

The materials for our research were DNA samples of 61 patients with metabolic syndrome and 58 patients with myocardial infarction without metabolic syndrome, who made up the main group.  The control group consisted of 155 “healthy” individuals without MS at the moment and in the anamnesis.  Molecular genetic studies were carried out in the Department of Molecular Medicine and Cellular Technologies of the RSNPMC of Hematology of the Republic of Uzbekistan.

Keywords: metabolic syndrome, obesity, insulin, allele, Try64Arg genetic polymorphism in the ADRB3 gene.

First page

75

Last page

77

For citation: Nabieva D.A., Musashaykhov U.Х., Boboev K.T., Musashaykhov Х.T. – INVESTIGATION OF THE GENETIC ASSOCIATION OF TRY64ARG POLYMORPHISM IN THE ADRB3 GENE WITH THE RISK OF METABOLIC SYNDROME AND MYOCARDIAL INFARCTION //New Day in Medicine 2023 4(54): 75-77 https://newdaymedicine.com/index.php/2023/07/01/l-242/

LIST OF REFERENCES:

1. De Brito Gonçalves Nascimento, Luciana et al. “Diabetic Patients with Cardiovascular Disease Show More Metabolic Syndrome than Nondiabetic Patients: Multicentric Study in the Northeast of Brazil.” Metabolic syndrome and related disorders vol. 19,4 (2021): 233-239. doi:10.1089/met.2020.0064
2. Erol Çetin. “Mental stress-induced myocardial ischemia, resistant hypertension, cardiovascular risk in metabolic syndrome from the PURE cohort, and more.” Anatolian journal of cardiology vol. 24,3 (2020): 125. doi:10.14744 /AnatolJCardiol.2020.9
3. Ferreira, João Pedro et al. “Metabolic syndrome in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a post hoc analyses of the EMPA-REG OUTCOME trial.” Cardiovascular diabetology vol. 19,1 200. 26 Nov. 2020, doi:10.1186/s12933-020-01174-6
4. Jenča Dominik et al. “Heart failure after myocardial infarction: incidence and predictors.” ESC heart failure vol. 8,1 (2021): 222-237. doi:10.1002/ehf2.13144
5. Gulati, Rajiv et al. “Acute Myocardial Infarction in Young Individuals.” Mayo Clinic proceedings vol. 95,1 (2020): 136-156. doi:10.1016/j.mayocp.2019.05.001
6. Gédéon Tara et al. “Acute Myocardial Infarction in Pregnancy.” Current problems in cardiology vol. 47,11 (2022): 101327. doi:10.1016/j.cpcardiol.2022.101327
7. Cho Young-Hye et al. “Biomarkers in metabolic syndrome.” Advances in clinical chemistry vol. 111 (2022): 101-156. doi:10.1016/bs.acc.2022.07.003
8. Son Da-Hye et al. “New markers in metabolic syndrome.” Advances in clinical chemistry vol. 110 (2022): 37-71. doi:10.1016/bs.acc.2022.06.002
9. Godfrey Timian M. et al. “Metabolic Syndrome Among American Indian and Alaska Native Populations: Implications for Cardiovascular Health.” Current hypertension reports vol. 24,5 (2022): 107-114. doi:10.1007/s11906-022-01178-5
10. Bovolini António et al. “Metabolic Syndrome Pathophysiology and Predisposing Factors.” International journal of sports medicine vol. 42,3 (2021): 199-214. doi:10.1055/a-1263-0898